Dementia is an important risk factor for delirium, but the optimal strategy for incorporating cognitive impairment into delirium risk assessment at the time of hospital admission is unknown. We compared 2 informant-based screening tools for dementia and mild cognitive impairment [AD8 and D = (MC) 2 ] to the Mini Mental State Examination (MMSE) and Mini-cog in predicting hospital-acquired delirium. This prospective cohort study at an academic medical center consisted of 162 medical inpatients over age 50 years without delirium upon admission. Each participant was evaluated using the MMSE, Mini-cog, AD8, and D = (MC) 2 upon admission and was assessed daily for delirium. An MMSEr24 carried a 5.5 [95% confidence intervals (CI), 2.7-11.1] relative risk for delirium, whereas cognitive impairment detected by the Mini-cog, D = (MC) 2 , or AD8 carried a 2-fold risk. Adding the D = (MC) 2 to the MMSE increased the sensitivity for predicting delirium from 52% (range, 32% to 73%) for the MMSE alone to 65% (range, 46% to 85%) if either test was positive. If both were positive, specificity was maximized at 97% (range, 94% to 100%), but sensitivity was 17% (range, 2% to 33%). The MMSE and Mini-cog identify a large proportion of patients at risk for hospital-acquired delirium, but the combination of performance-based and an informant-based screens may maximize specificity and sensitivity.
D elirium is characterized by an acute and fluctuating cognitive disturbance characterized chiefly by impaired attention. 1, 2 Delirium occurs in 10% to 60% of hospitalized elderly patients. 3, 4 Delirium is associated with protracted hospital stays and higher in-hospital and postdischarge morbidity and mortality. [5] [6] [7] [8] [9] Failure to identify and prevent delirium carries an estimated annual cost of 38 to 152 billion dollars. 10 However, evidence-based interventions to prevent delirium exist, providing opportunities to improve patient outcomes and highlighting the need for effective risk-assessment tools. 11, 12 A key risk factor for delirium in hospitalized patients is baseline cognitive impairment: two thirds of delirium cases occur in patients with dementia. 8, 13 However, baseline cognitive function is rarely known at the time of hospital admission, and patients with early-stage dementia or mild cognitive impairment rarely carry that diagnosis in their medical record. [14] [15] [16] Therefore, an efficient method of identifying patients with cognitive dysfunction at admission is a critical part of delirium risk assessment.
Cognitive function can be assessed using performancebased measures such as the Mini Mental State Examination (MMSE) or informant-based measures. 17, 18 The MMSE is a widely used method for grading cognitive function, and has been used in the development of existing delirium prediction tools. 7, 19 However, administration of the MMSE can be time consuming, is insensitive for detecting early dementia, and results in the acute setting may not accurately reflect baseline cognitive function because of factors such as fatigue and inattention. 20 Some authors advocate using the brief Mini-cog, as an alternative performancebased screen for cognitive dysfunction. 21, 22 Informant-based screening tools may be more sensitive for detecting early dementia, are less likely to be influenced by the acute condition of the patient, and may complement performance-based tools when used in combination. 23 The AD8 and Dementia = (MC) 2 are 2 very brief informantbased screening tools that detect early dementia and mild cognitive impairment (Table 1) . 24, 25 We prospectively administered these screening tools at the time of admission to a cohort of nondelirious adult medical inpatients who were subsequently followed for the development of delirium during their hospitalization. We hypothesized that the combination of informant-based and performance-based screening tools would be more sensitive and specific than either tool alone.
METHODS

Design and Setting
This was a nested prospective cohort study including all subjects with available informants enrolled in a larger study of delirium prediction at an academic medical center.
Participants and Measurements
Subjects were identified by reviewing daily admission logs for the University of California, San Francisco (UCSF) Moffitt-Long and Mount Zion hospitals. All nonintensive care unit patients aged 50 years or older admitted through the emergency department to the medicine, cardiology, or neurology services from May 2010 to November 2010 were screened for eligibility through chart review or in person within 24 hours of admission by a trained research assistant. In-person screening included an assessment for delirium using the long version of the Confusion Assessment Method (CAM). 26 Subjects who were delirious upon initial evaluation, did not have an available informant, were non-English speaking or severely aphasic, or were admitted for alcohol withdrawal or comfort/hospice care were excluded. All patients or their surrogates provided written informed consent, and the study was approved by the Institutional Review Board at UCSF.
Of 1241 patients screened, 439 were eligible for enrollment. Of these, 180 declined to participate, 50 were discharged before the first follow-up visit, and 47 did not have an available informant, leaving 162 included subjects.
Upon enrollment, cognitive performance was assessed with the MMSE and the Mini-cog. 17, 27 Permission for administration of the MMSE was granted by Psychological Assessment Resources Inc., and each administration was paid for. The AD8 and D = (MC) 2 questionnaires were administered to informants. 24, 25 Baseline data regarding known delirium risk factors (age, visual and hearing impairment, alcohol use, depression, prior history of dementia in the medical record, illness severity, and dehydration) were collected from subjects and charts for use in the multivariable regression model. Details about the measurement of these variables have been described previously. 19 
Assessment of Outcomes
All subjects were assessed for delirium for 6 consecutive days after enrollment or until discharge, whichever came first. The short CAM, an internationally recognized and validated tool, was used to assess delirium. 26 The short CAM consists of a scripted interview, an MMSE and forward digit span, and a conversation with the subject's nurse for any change or fluctuations in mental status.
Follow-up assessments were performed by research assistants who were not blinded to the initial D = (MC) 2 or AD8 score. Some weekend follow-ups were performed by PGY-2, PGY-3, or PGY-4 neurology residents blinded to the initial assessment. Research assistants were trained by a board-certified neurologist (V.C.D.) in the administration and interpretation of the CAM using published methods before enrollment of any subjects. 28 Training included the performance of independent long-version CAMs by the trainer and the trainee on a series of delirious and nondelirious patients until there was consistent agreement for each item on the CAM in 5 consecutive patients. In addition, a board-certified neurologist supervised the first 5 administrations of the CAM performed by each research assistant. All potential outcomes were validated in person by a board-certified neurologist (V.C.D. or S.A.J.) blinded to the initial assessment.
Data Analysis
All variables were dichotomized with the exception of age. On the MMSE, a score of r24 was considered evidence of dementia. The Mini-cog was considered positive if the score was 0, 1, or 2. A score of Z2 qualifies as a positive screen on the D = (MC) 2 and likewise for the AD8. To test for selection bias, we compared baseline characteristics between subjects included in the study and those excluded due to the lack of an informant. We then compared baseline characteristics between patients who developed delirium and those who did not using Fisher exact test or w 2 test for categorical variables and the 2-tailed t test for continuous variables. Clinical test characteristics for each of the 4 cognitive screening tools used alone or in combination were calculated with 95% confidence intervals (CI) using published methods. 29 To determine whether cognitive screening tools predict delirium independent of other known risk factors, we created multivariable logistic regression models incorporating variables known to be risk factors for delirium from previous studies: known dementia, age, vision impairment, hearing impairment, high BUN/Cr ratio, depression, and severe illness. Alcohol dependence was excluded from the multivariable analysis as none of the 7 patients who 
RESULTS
The cohort consisted of 162 elderly patients (mean age, 69 ± 12 y) and included more men than women ( Table 1) . The subjects were predominantly white, with the remainder split evenly between blacks and Asian/Pacific Islander. Seventy-five percent of the informants were family members, 16% friends, and 4% caregivers or case managers. The mean screening MMSE score was 27 (range, 7 to 30). A similar proportion of patients screened positive for cognitive impairment with the AD8 and the D = (MC) 2 (21% vs. 15%, P = 0.15).
Delirium developed in 23 (14%) patients within the first 6 days of their hospitalization (Table 1) . Patients who developed delirium were older, more likely to carry a diagnosis of dementia, or have moderate or severe illness. Patients with delirium were also more likely to have a low MMSE or Mini-cog score or screen positive on the AD8 or D = (MC) 2 ( Table 1) .
We calculated the relative risk, sensitivity, specificity, and likelihood ratios (LR + and LR À) for the ability of the MMSE, Mini-cog, AD8, D = (MC) 2 , and the MMSE in combination with AD8 or D = (MC) 2 to predict development of delirium ( Table 2 ). The MMSE and Mini-cog each demonstrated the highest sensitivity at 52% (95% CI, 32%-73%) for both tests, whereas the Mini-cog was the least specific at 75% (95% CI, 68%-82%). When considered in combination, sensitivity for delirium prediction rose to 65% to 70% if either informant-based measure or the MMSE was positive. Specificity was highest when both the D = (MC) 2 and the MMSE were positive [97% (95% CI, 94%-100%); Table 2 ]. The results for the combination of informant-based measures with the Mini-cog were similar except for a loss of specificity.
Of the 4 cognitive screening tools, only a low MMSE score reached statistical significance as an independent predictor in multivariable logistic regression incorporating known delirium risk factors (Table 3 ). Other independent predictors of delirium in the model included age [OR per year = 1.07 (95% CI, 1.01-1.13), P = 0.02] and moderate or severe illness [OR = 14.7 (95% CI, 1.6-136.1), P = 0.02].
In clinical practice, one might choose to omit cognitive screening when trying to predict delirium in patients who are already diagnosed with dementia. We therefore repeated our analysis after omitting those patients with a known dementia diagnosis. Only 6 patients in the cohort carried a diagnosis of dementia in their medical record; 3 of these became delirious and all 3 screened positive with the 4 cognitive screening tools. With these 6 patients removed from the analysis, the relative risk for delirium among those who screened positive with the D = (MC) 2 or AD8 no longer reached statistical significance [1.8 (range, 0.7 to 4.8), P = 0.3 and 2.0 (range, 0.8 to 4.7), P = 0.1, respectively], whereas it remained significant with both the MMSE and Mini-cog [5.0 (range, 2.3 to 10.6), P < 0.001 and 2.3 (range, 1.0 to 5.2), P = 0.04, respectively].
To look for possible bias introduced by excluding those patients without informants, we compared delirium risk factors and outcomes in those with and without informants. Patients without informants were younger (65 vs. 69 y, P = 0.03), were more likely to have poor vision (45% vs. 26%, P = 0.01), and were less likely to have a BUN/Cr ratio >18 (19% vs. 44%, P = 0.002). There was no difference in the mean MMSE score (27 in both groups, P = 0.88) or the proportion of patients with low MMSE (17% in both groups, P = 0.95) or Mini-cog scores (28% vs. 29%, P = 0.91). Two (4%) excluded patients and 23 (14%) included patients became delirious (P = 0.06).
DISCUSSION
The MMSE, Mini-cog, AD8, and D = (MC) 2 are tools that have been validated for the detection of dementia and cognitive impairment, which are leading risk factors for developing delirium in medically hospitalized patients. Low MMSE or Mini-cog scores are proven risk factors for delirium, but informant-based measures of cognitive function have not been as extensively studied as tools for delirium prediction. In this study we sought to determine whether 2 simple informant-based cognitive screening tools could either replace or augment the MMSE or Mini-cog in the risk stratification of hospital-acquired delirium. We found that the AD8 and the D = (MC) 2 can each identify patients at risk for delirium. However, both performance-based measures captured a greater percentage of patients at risk for delirium without sacrificing specificity. If either a performance-based measure or an informant-based measure was positive, 65% to 70% of patients who would eventually develop delirium could be identified, and if both measures were positive delirium could be predicted with high specificity.
LRs help clinicians determine the posttest probability of an outcome for individual patients. The incidence of delirium in our cohort was 14%, comparable with prior studies. 13 As an illustrative example, if a patient were to screen positive with either the MMSE or the D = (MC) 2 , based on the LRs presented here the risk of that patient developing delirium would be 34%. A negative screen on both tests would result in a delirium risk of 7%. If a patient screened positive on both the MMSE and the D = (MC) 2 , the risk of developing delirium would be 49%.
Although dementia is an important risk factor for delirium, it alone does not account for all cases. Age independent of dementia, severe illness or major surgery, hip fracture, and sensory impairment are also known risk factors in addition to iatrogenic precipitants such as medications and sleep deprivation. Thus there is an inevitable ceiling effect in the sensitivity of any dementia test used to assess delirium risk. This could explain the observation that even when the screening tools studied here were used in combination to maximize sensitivity, only 70% of delirium cases could be predicted. Therefore any comprehensive delirium risk-assessment model must take into consideration factors beyond cognitive impairment.
Our multivariable analysis suggests that cognitive impairment as measured by the MMSE is an independent risk factor for delirium, whereas the Mini-cog, D = (MC) 2 , and AD8 are not. This may be a type II error due to the effect of our small sample size, which is a limitation of this study. A further limitation is the predictive ability of the D = (MC) 2 and AD8 was only apparent when the 6 patients who already carried a diagnosis of dementia in their medical record were incorporated into the analysis, suggesting that in this cohort the informant-based screening tools were not as sensitive as the MMSE in detecting incident cognitive impairment as opposed to prevalent dementia. However, in many cases a patient's full medical record may not be available at the time of hospital admission and an informant-based screening tool may be a sensitive proxy.
Additional limitations of this study include the lack of informants for every patient in the full cohort and the lack of ethnic diversity. It is possible that an unmeasured bias was introduced by excluding patients without informants from this study. The included patients were older than the excluded patients, which could explain the trend toward more delirium in the nested cohort. It is unlikely there would have been a major difference between D = (MC) 2 and AD8 results between included and excluded patients, because there was no difference in MMSE and Mini-cog scores. The difference in BUN/Cr ratios would not be expected to introduce bias as it was not associated with delirium in either the nested or the entire cohort. An additional limitation is the fact that delirium was only assessed by the CAM once daily; because delirium fluctuates, it is possible some cases were missed. We tried to mitigate this by including an interview with each subject's caregiver or bedside nurse asking about overnight events and fluctuations in cognition over the preceding 24 hours. The sample make up of predominantly English-speaking whites precludes generalizing our results to other ethnicities or non-English speakers. In addition, the population only consisted of medical inpatients, hence we are unable to generalize any findings to surgical patients.
In conclusion, this study provides evidence for the relative effectiveness of 4 different methods of screening for cognitive dysfunction to predict hospital-acquired delirium, 2 of which have not been studied in this context previously. In addition to reinforcing the understanding that both the MMSE and Mini-cog predict delirium, it gives health care providers 2 additional informant-based options for delirium prediction.
